Digital repository of Slovenian research organisations

Show document
A+ | A- | SLO | ENG

Title:Obsevanje bolnic z eno do tremi pozitivnimi pazdušnimi bezgavkami po mastektomiji - da ali ne
Authors:But Hadžić, Jasna (Author)
Bilban-Jakopin, Cvetka (Author)
Tipology:1.04 - Professional Article
Organisation:Logo OI - Institute of Oncology
Abstract:Obsevanje po modificirani radikalni mastektomiji (MRM) pri bolnicah z 1-3 pozitivnimi pazdušnimi bezgavkami je že vrsto let predmet strokovnih razprav. Kljub čedalje pogostejšim dokazom o dobrobiti obsevanja po MRM pri bolnicah s t. i. vmesnim tveganjem za lokalno ponovitev pa še vedno ostajajo številna protislovja in nerešena vprašanja o pomenu učinka izboljšane lokalne kontrole na preživetje, o posledicah pozne kardiotoksičnosti obsevanja ob uporabi sodobnih sistemskih zdravil ter o izbiri območja obsevanja in podskupin bolnic, primernih za obsevanje. Večina mednarodnih smernic in sporazumov svetuje obsevanje po MRM v podskupinah bolnic z 1-3 pozitivnimi pazdušnimi bezgavkami, s tehtnim premislekom med koristjo in tveganjem tega zdravljenja.
Year of publishing:2010
COBISS_ID:1056379 Link is opened in a new window
ISSN on article:1408-1741
OceCobissID:65324032 Link is opened in a new window
Files:.pdf PDF - Presentation file, download (136,78 KB)
Onkološki inštitut
Rights:by Authors
Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.


License:CC BY 4.0, Creative Commons Attribution 4.0 International
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:31.08.2018

Secondary language

Title:Patients with One to Three Positive Axillary Lymph Nodes Following Mastectomy: Dilemma Whether to Use Postoperative Radiation Therapy or No
Abstract:Radiation therapy following a modified radical mastectomy (MRM) applied in the patients with one to three positive axillary lymph nodes has long been a primary issue of many debates. Despite most convincing evidence of the benefits of the post-MRM radiation therapy of the patients at moderate risk for local recurrence, a number of issues and questions, such the effect of improved local control on survival as well as the late cardiotoxic sequelae of radiation therapy irrespective of the most up-to-date systemic therapy, accurate radiation field planning and proper selection of subgroups of patients eligible for radiation, have remained unresolved. In general, the majority of international guidelines and agreements recommend, though not without a careful benefit/risk assessment, performing post-MRM radiation therapy in the subgroup of patients with one to three positive axillary lymph nodes.